JP Patent

JP7516029B2 — Ｋｒａｓｇ１２ｃ阻害剤化合物の重要な中間体の改良合成法

Assigned to アムジエン・インコーポレーテツド · Expires 2024-07-16 · 2y expired

What this patent protects

Patent listed against mobocertinib-succinate.

Drugs covered by this patent

mobocertinib-succinate (MOBOCERTINIB SUCCINATE)

Patent Metadata

Patent number: JP7516029B2
Jurisdiction: JP
Classification: —
Expires: 2024-07-16
Drug substance claim: No
Drug product claim: No
Assignee: アムジエン・インコーポレーテツド
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.